These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3938862)

  • 1. [Salmonellosis associated with hepatosplenic schistosomiasis mansoni. Effect of praziquantel].
    Shikanai-Yasuda MA; de Carvalho SA; Yasuda PH; Del Negro G; Shiroma M; Amato Neto V
    Rev Inst Med Trop Sao Paulo; 1985; 27(5):286-91. PubMed ID: 3938862
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of prolongued septicemic enterobacteriosis with praziquantel].
    Emanuel A; Castro CN; Pires LL; Prata A
    Rev Soc Bras Med Trop; 1988; 21(2):75-6. PubMed ID: 3150596
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific treatment of advanced schistosomiasis liver disease in man: favourable results.
    Coutinho A; Domingues AL
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():335-40. PubMed ID: 3151109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schistosomal glomerulopathy: a putative role for commonly associated Salmonella infection.
    Abdul-Fattah MM; Yossef SM; Ebraheem ME; Nasr ME; Hassan MA; Abdul Wahab SE
    J Egypt Soc Parasitol; 1995 Apr; 25(1):165-73. PubMed ID: 7602159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmonella-S. mansoni association in patients with acquired immunodeficiency syndrome.
    Lambertucci JR; Rayes AA; Gerspacher-Lara R
    Rev Inst Med Trop Sao Paulo; 1998; 40(4):233-5. PubMed ID: 9876436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Praziquantel for treatment of schistosomiasis in patients with advanced hepatosplenomegaly.
    Bassily S; Farid Z; Dunn M; el-Masry NA; Stek M
    Ann Trop Med Parasitol; 1985 Dec; 79(6):629-34. PubMed ID: 3938936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profile of portal hypertension in hepatosplenic schistosomiasis.
    el-Hawey AM; Abou-Taleb SA; el-Gammal HA; Abdel-Rahman MM; Sabry AA
    J Egypt Soc Parasitol; 1992 Aug; 22(2):305-9. PubMed ID: 1500767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatosplenic schistosomiasis.
    Lubeya M; Muloshi C; Baboo KS; Sianongo S; Kelly P
    Lancet; 2010 Nov; 376(9753):1645. PubMed ID: 21075257
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutical evaluation of different dose regimens of praziquantel in schistosomiasis mansoni, based on the quantitative oogram technique.
    da Cunha AS; Cançado JR; de Rezende GL
    Rev Inst Med Trop Sao Paulo; 1987; 29(5):295-304. PubMed ID: 3136532
    [No Abstract]   [Full Text] [Related]  

  • 10. Fulminant hepatitis associated with Schistosoma mansoni.
    Shinawi M; Kovalski Y; Berkowitz D; Brik R; Kassis I; Shamir R
    J Pediatr Gastroenterol Nutr; 2001 May; 32(5):605-7. PubMed ID: 11429526
    [No Abstract]   [Full Text] [Related]  

  • 11. [Renal involvement in a Salmonella-Schistosoma mansoni association].
    Lambertucci JR; Godoy P; Bambirra EA; Neves J; Tafuri WL; Leite VH
    Rev Soc Bras Med Trop; 1987; 20(2):83-90. PubMed ID: 3148973
    [No Abstract]   [Full Text] [Related]  

  • 12. Praziquantel efficacy against schistosomiasis mansoni in schoolchildren in north-west Ethiopia.
    Degu G; Mengistu G; Jones J
    Trans R Soc Trop Med Hyg; 2002; 96(4):444-5. PubMed ID: 12497985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of hepatosplenic schistosomiasis mansoni with praziquantel].
    Coutinho AD; Domingues AL; Florêncio JN; Almeida ST
    Rev Inst Med Trop Sao Paulo; 1984; 26(1):38-50. PubMed ID: 6379831
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of single-dose praziquantel on morbidity and mortality resulting from intestinal schistosomiasis.
    Kheir MM; Baraka OZ; el-Tom IA; Mukhtar MM; Homieda MM
    East Mediterr Health J; 2000; 6(5-6):926-31. PubMed ID: 12197350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Praziquantel in treatment of S. mansoni and S. haematobium infections.
    Ahmed TH; Ali AA; Bassiouni GA; Omer SH; Shalaby MA
    J Egypt Soc Parasitol; 1988 Jun; 18(1):313-24. PubMed ID: 3131447
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
    Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
    Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of praziquantel on platelet levels in mice infected with S. mansoni.
    Wambayi EJ; Kasili EG; Kimani G; Waruinge D
    East Afr Med J; 1993 Oct; 70(10):665-6. PubMed ID: 8187668
    [No Abstract]   [Full Text] [Related]  

  • 19. T cell phenotype alterations in hepatosplenic schistosomiasis mansoni normalize after chemotherapy.
    Zwingenberger K; Harms G; Vergetti de Siqueira JG; Correia Dacal AR; Jansen-Rosseck R; Bienzle U; Feldmeier H
    Immunobiology; 1989 Oct; 179(4-5):342-52. PubMed ID: 2515152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the in vitro cell proliferation of lymphocytes from Manson's schistosomiasis patients treated with praziquantel.
    Almeida TM; da Silva LC; Almeida VF; Beçak W
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():243. PubMed ID: 3151098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.